ABCDx is a Swiss–Spanish company revolutionizing emergency brain and vascular diagnostics through proprietary biomarkers and artificial intelligence. Its technology enables rapid, accurate, and accessible pre-hospital detection of large vessel occlusion (LVO) strokes and pulmonary embolism (PE).